

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | detection of light stimulus involved in visual perception (GO:0050908) | 6.20636524 |
| 2 | detection of light stimulus involved in sensory perception (GO:0050962) | 6.20636524 |
| 3 | synaptic vesicle exocytosis (GO:0016079) | 5.82146612 |
| 4 | protein localization to synapse (GO:0035418) | 5.49135211 |
| 5 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 5.25899589 |
| 6 | protein neddylation (GO:0045116) | 5.25149815 |
| 7 | response to pheromone (GO:0019236) | 5.24084628 |
| 8 | thrombin receptor signaling pathway (GO:0070493) | 5.10382559 |
| 9 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 4.94941975 |
| 10 | regulation of platelet aggregation (GO:0090330) | 4.94089458 |
| 11 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 4.87390568 |
| 12 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 4.75015528 |
| 13 | neuron cell-cell adhesion (GO:0007158) | 4.72555226 |
| 14 | negative regulation of protein localization to cell surface (GO:2000009) | 4.71079142 |
| 15 | neutrophil activation involved in immune response (GO:0002283) | 4.65966309 |
| 16 | vocalization behavior (GO:0071625) | 4.53850469 |
| 17 | innervation (GO:0060384) | 4.52703192 |
| 18 | cellular potassium ion homeostasis (GO:0030007) | 4.52369044 |
| 19 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.51570712 |
| 20 | positive regulation of endothelial cell differentiation (GO:0045603) | 4.48551007 |
| 21 | adenosine receptor signaling pathway (GO:0001973) | 4.48075672 |
| 22 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.46266033 |
| 23 | relaxation of smooth muscle (GO:0044557) | 4.43914477 |
| 24 | sodium ion export (GO:0071436) | 4.43017004 |
| 25 | synaptic vesicle endocytosis (GO:0048488) | 4.39696517 |
| 26 | positive regulation of synapse maturation (GO:0090129) | 4.35737183 |
| 27 | negative regulation of heart rate (GO:0010459) | 4.35216904 |
| 28 | retinal rod cell development (GO:0046548) | 4.34516973 |
| 29 | regulation of platelet activation (GO:0010543) | 4.31900344 |
| 30 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 4.24553932 |
| 31 | membrane depolarization during action potential (GO:0086010) | 4.18731002 |
| 32 | cell migration in hindbrain (GO:0021535) | 4.11354865 |
| 33 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.08414872 |
| 34 | regulation of integrin-mediated signaling pathway (GO:2001044) | 4.08305761 |
| 35 | negative regulation of platelet activation (GO:0010544) | 4.07109954 |
| 36 | positive regulation of receptor recycling (GO:0001921) | 4.05233091 |
| 37 | regulation of lipoprotein metabolic process (GO:0050746) | 4.03702206 |
| 38 | mating behavior (GO:0007617) | 4.03536480 |
| 39 | blood coagulation, intrinsic pathway (GO:0007597) | 4.01930164 |
| 40 | negative regulation of norepinephrine secretion (GO:0010700) | 4.00327021 |
| 41 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.99249620 |
| 42 | urinary tract smooth muscle contraction (GO:0014848) | 3.98711092 |
| 43 | potassium ion homeostasis (GO:0055075) | 3.92897916 |
| 44 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.88427396 |
| 45 | muscle filament sliding (GO:0030049) | 3.82902296 |
| 46 | actin-myosin filament sliding (GO:0033275) | 3.82902296 |
| 47 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.80643876 |
| 48 | regulation of synapse maturation (GO:0090128) | 3.79856375 |
| 49 | regulation of synaptic vesicle transport (GO:1902803) | 3.78700201 |
| 50 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.74737332 |
| 51 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.71252727 |
| 52 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.69528498 |
| 53 | glutamate secretion (GO:0014047) | 3.66306080 |
| 54 | synapse assembly (GO:0007416) | 3.65889842 |
| 55 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.65194490 |
| 56 | negative regulation of heart contraction (GO:0045822) | 3.63317646 |
| 57 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.63034474 |
| 58 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.62357250 |
| 59 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.61635910 |
| 60 | platelet aggregation (GO:0070527) | 3.53976706 |
| 61 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.53799226 |
| 62 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.53212322 |
| 63 | striatum development (GO:0021756) | 3.53206531 |
| 64 | retinal ganglion cell axon guidance (GO:0031290) | 3.52882428 |
| 65 | cell communication by electrical coupling (GO:0010644) | 3.51370214 |
| 66 | synaptic vesicle maturation (GO:0016188) | 3.49598997 |
| 67 | glutamate receptor signaling pathway (GO:0007215) | 3.49207246 |
| 68 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.44155233 |
| 69 | actin-mediated cell contraction (GO:0070252) | 3.43756255 |
| 70 | synaptic vesicle transport (GO:0048489) | 3.43174763 |
| 71 | establishment of synaptic vesicle localization (GO:0097480) | 3.43174763 |
| 72 | retinal cone cell development (GO:0046549) | 3.41066447 |
| 73 | detection of temperature stimulus (GO:0016048) | 3.40989307 |
| 74 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.39268485 |
| 75 | membrane hyperpolarization (GO:0060081) | 3.38129900 |
| 76 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 3.36816893 |
| 77 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 3.36816893 |
| 78 | regulation of endothelial cell differentiation (GO:0045601) | 3.35498476 |
| 79 | neurotransmitter secretion (GO:0007269) | 3.34984681 |
| 80 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 3.34280347 |
| 81 | prepulse inhibition (GO:0060134) | 3.34128648 |
| 82 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.34024783 |
| 83 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.33928360 |
| 84 | regulation of receptor recycling (GO:0001919) | 3.33653623 |
| 85 | exploration behavior (GO:0035640) | 3.32659530 |
| 86 | relaxation of muscle (GO:0090075) | 3.32044048 |
| 87 | neuronal action potential (GO:0019228) | 3.30248153 |
| 88 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.29958413 |
| 89 | regulation of synapse structural plasticity (GO:0051823) | 3.28149814 |
| 90 | negative regulation of appetite (GO:0032099) | 3.27407241 |
| 91 | negative regulation of response to food (GO:0032096) | 3.27407241 |
| 92 | neurofilament cytoskeleton organization (GO:0060052) | 3.26196466 |
| 93 | regulation of neurotransmitter secretion (GO:0046928) | 3.25935913 |
| 94 | calcium ion import (GO:0070509) | 3.24693968 |
| 95 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.24341298 |
| 96 | cellular sodium ion homeostasis (GO:0006883) | 3.22712332 |
| 97 | negative regulation of thymocyte apoptotic process (GO:0070244) | 3.21924265 |
| 98 | polyamine biosynthetic process (GO:0006596) | 3.21497380 |
| 99 | platelet degranulation (GO:0002576) | 3.21426311 |
| 100 | low-density lipoprotein particle remodeling (GO:0034374) | 3.20882088 |
| 101 | neuron-neuron synaptic transmission (GO:0007270) | 3.20845450 |
| 102 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.19439524 |
| 103 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.19296914 |
| 104 | postsynaptic membrane organization (GO:0001941) | 3.15648010 |
| 105 | cellular response to epinephrine stimulus (GO:0071872) | 3.15351014 |
| 106 | positive regulation of cAMP-mediated signaling (GO:0043950) | 3.14826600 |
| 107 | phospholipid homeostasis (GO:0055091) | 3.12890495 |
| 108 | presynaptic membrane assembly (GO:0097105) | 3.11480469 |
| 109 | long-term synaptic potentiation (GO:0060291) | 3.10240813 |
| 110 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.09196480 |
| 111 | axon cargo transport (GO:0008088) | 3.08915198 |
| 112 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.08684175 |
| 113 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.08145343 |
| 114 | relaxation of cardiac muscle (GO:0055119) | 3.07721771 |
| 115 | activation of protein kinase A activity (GO:0034199) | 3.07287308 |
| 116 | regulation of neurotransmitter transport (GO:0051588) | 3.07239518 |
| 117 | response to epinephrine (GO:0071871) | 3.06593849 |
| 118 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.06120169 |
| 119 | sarcomere organization (GO:0045214) | 3.05996508 |
| 120 | regulation of skeletal muscle contraction (GO:0014819) | 3.05421696 |
| 121 | neurotransmitter transport (GO:0006836) | 3.04635235 |
| 122 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.02649462 |
| 123 | neuronal action potential propagation (GO:0019227) | 3.01962216 |
| 124 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.01404204 |
| 125 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.01244715 |
| 126 | dendrite morphogenesis (GO:0048813) | 3.00623235 |
| 127 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.00566471 |
| 128 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.00566471 |
| 129 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 3.00094896 |
| 130 | establishment of mitochondrion localization (GO:0051654) | 2.99060999 |
| 131 | positive regulation of Rho protein signal transduction (GO:0035025) | 2.98873514 |
| 132 | homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156) | 2.98135320 |
| 133 | neuron recognition (GO:0008038) | 2.98038840 |
| 134 | potassium ion transmembrane transport (GO:0071805) | 2.97821814 |
| 135 | cellular potassium ion transport (GO:0071804) | 2.97821814 |
| 136 | synaptic transmission, glutamatergic (GO:0035249) | 2.94796490 |
| 137 | negative regulation of blood circulation (GO:1903523) | 2.94572807 |
| 138 | potassium ion export (GO:0071435) | 2.92879593 |
| 139 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 2.91650495 |
| 140 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.91598413 |
| 141 | response to histamine (GO:0034776) | 2.91029363 |
| 142 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.90288456 |
| 143 | positive regulation of mast cell activation (GO:0033005) | 2.89622636 |
| 144 | positive regulation of potassium ion transport (GO:0043268) | 2.89346684 |
| 145 | eye photoreceptor cell development (GO:0042462) | 2.89098904 |
| 146 | establishment of vesicle localization (GO:0051650) | 2.88970671 |
| 147 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 2.88294261 |
| 148 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 2.88294261 |
| 149 | behavioral response to cocaine (GO:0048148) | 2.88144574 |
| 150 | negative regulation of microtubule polymerization (GO:0031115) | 2.87915212 |
| 151 | regulation of relaxation of muscle (GO:1901077) | 2.87747189 |
| 152 | regulation of vesicle fusion (GO:0031338) | 2.87310046 |
| 153 | positive regulation of synapse assembly (GO:0051965) | 2.87304023 |
| 154 | regulation of homotypic cell-cell adhesion (GO:0034110) | 2.87230241 |
| 155 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.86279810 |
| 156 | negative regulation of dendrite development (GO:2000171) | 2.86105114 |
| 157 | synaptic transmission (GO:0007268) | 2.85851250 |
| 158 | fusion of sperm to egg plasma membrane (GO:0007342) | 2.85279306 |
| 159 | membrane depolarization (GO:0051899) | 2.84928783 |
| 160 | photoreceptor cell development (GO:0042461) | 2.84779970 |
| 161 | lipoxygenase pathway (GO:0019372) | 2.83019611 |
| 162 | positive regulation of myoblast differentiation (GO:0045663) | 2.82339795 |
| 163 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.81208149 |
| 164 | regulation of female receptivity (GO:0045924) | 2.80202176 |
| 165 | negative regulation of catecholamine secretion (GO:0033604) | 2.79222813 |
| 166 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.78823274 |
| 167 | myofibril assembly (GO:0030239) | 2.78093947 |
| 168 | positive regulation of systemic arterial blood pressure (GO:0003084) | 2.77822303 |
| 169 | negative regulation of muscle contraction (GO:0045932) | 2.76512767 |
| 170 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 2.76496903 |
| 171 | positive regulation of muscle hypertrophy (GO:0014742) | 2.76496903 |
| 172 | platelet activation (GO:0030168) | 2.74563545 |
| 173 | negative regulation of hematopoietic progenitor cell differentiation (GO:1901533) | 2.72839716 |
| 174 | neutrophil activation (GO:0042119) | 2.71227041 |
| 175 | angiogenesis involved in wound healing (GO:0060055) | 2.69714993 |
| 176 | termination of G-protein coupled receptor signaling pathway (GO:0038032) | 2.65002086 |
| 177 | striated muscle contraction (GO:0006941) | 2.64949509 |
| 178 | regulation of norepinephrine secretion (GO:0014061) | 2.64399907 |
| 179 | purinergic receptor signaling pathway (GO:0035587) | 2.64115683 |
| 180 | cardiac muscle contraction (GO:0060048) | 2.62539641 |
| 181 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 2.60716149 |
| 182 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.59617156 |
| 183 | actin filament-based movement (GO:0030048) | 2.59572364 |
| 184 | cardiac myofibril assembly (GO:0055003) | 2.56343682 |
| 185 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.55860598 |
| 186 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.55860598 |
| 187 | beta-amyloid metabolic process (GO:0050435) | 2.55506219 |
| 188 | cardiac muscle hypertrophy (GO:0003300) | 2.53861538 |
| 189 | extracellular fibril organization (GO:0043206) | 2.52732140 |
| 190 | regulation of actin filament-based movement (GO:1903115) | 2.51689803 |
| 191 | termination of signal transduction (GO:0023021) | 2.50723147 |
| 192 | regulation of protein localization to cell surface (GO:2000008) | 2.48201890 |
| 193 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.47584401 |
| 194 | striated muscle hypertrophy (GO:0014897) | 2.45615079 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.15045301 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.52001593 |
| 3 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 3.42128318 |
| 4 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 2.87923682 |
| 5 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.81831476 |
| 6 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.80340215 |
| 7 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.72853497 |
| 8 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.65867856 |
| 9 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.54690767 |
| 10 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.54559715 |
| 11 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.54132179 |
| 12 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.47615408 |
| 13 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.43238976 |
| 14 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.39428697 |
| 15 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.39428697 |
| 16 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.34339645 |
| 17 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.32900585 |
| 18 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.32547490 |
| 19 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.30111080 |
| 20 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.29095997 |
| 21 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.25377830 |
| 22 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.22548562 |
| 23 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.20987574 |
| 24 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.19737642 |
| 25 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.14513994 |
| 26 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.09102437 |
| 27 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.09097028 |
| 28 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.08765841 |
| 29 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.04841751 |
| 30 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.04281208 |
| 31 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.01467721 |
| 32 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.01266483 |
| 33 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.00770793 |
| 34 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.00084326 |
| 35 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.99546261 |
| 36 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.99368820 |
| 37 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.95701017 |
| 38 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.92902967 |
| 39 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.85274588 |
| 40 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.84814111 |
| 41 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.82358337 |
| 42 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.79160188 |
| 43 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.77928892 |
| 44 | P300_19829295_ChIP-Seq_ESCs_Human | 1.77745897 |
| 45 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.75925755 |
| 46 | * RNF2_27304074_Chip-Seq_NSC_Mouse | 1.71126204 |
| 47 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.70326748 |
| 48 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.68545418 |
| 49 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.64957940 |
| 50 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.64286642 |
| 51 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.63032651 |
| 52 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.62634503 |
| 53 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.58456121 |
| 54 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.58456121 |
| 55 | FUS_26573619_Chip-Seq_HEK293_Human | 1.56763951 |
| 56 | * P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.56298182 |
| 57 | GATA1_19941826_ChIP-Seq_K562_Human | 1.52008157 |
| 58 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.51118474 |
| 59 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.46878154 |
| 60 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.46770298 |
| 61 | AR_25329375_ChIP-Seq_VCAP_Human | 1.45524318 |
| 62 | GATA2_19941826_ChIP-Seq_K562_Human | 1.45122495 |
| 63 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.43045650 |
| 64 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.42780161 |
| 65 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.42304733 |
| 66 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.39370929 |
| 67 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.36040878 |
| 68 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.35723707 |
| 69 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.35622853 |
| 70 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.35093588 |
| 71 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.34682181 |
| 72 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.34146238 |
| 73 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.34059392 |
| 74 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.33562987 |
| 75 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.33292595 |
| 76 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.32843019 |
| 77 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.32359961 |
| 78 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.31936654 |
| 79 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.29899606 |
| 80 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.29094077 |
| 81 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.29031382 |
| 82 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.28376203 |
| 83 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.24805992 |
| 84 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.24779566 |
| 85 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.24407011 |
| 86 | VDR_22108803_ChIP-Seq_LS180_Human | 1.23411694 |
| 87 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.21364170 |
| 88 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.20474604 |
| 89 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.20031633 |
| 90 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.19144052 |
| 91 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.19144052 |
| 92 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.18765222 |
| 93 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.18512265 |
| 94 | * AR_19668381_ChIP-Seq_PC3_Human | 1.17929234 |
| 95 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.17791253 |
| 96 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.15704919 |
| 97 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.14943036 |
| 98 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.14368967 |
| 99 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.13626629 |
| 100 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.12720707 |
| 101 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.12610107 |
| 102 | GATA1_22025678_ChIP-Seq_K562_Human | 1.12253881 |
| 103 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.11925495 |
| 104 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.11366573 |
| 105 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.10973953 |
| 106 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.10446003 |
| 107 | TP53_16413492_ChIP-PET_HCT116_Human | 1.09420681 |
| 108 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.08335695 |
| 109 | EWS_26573619_Chip-Seq_HEK293_Human | 1.07300849 |
| 110 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.07285889 |
| 111 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.07235609 |
| 112 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.07157872 |
| 113 | KDM2B_26808549_Chip-Seq_REH_Human | 1.07136065 |
| 114 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.07085673 |
| 115 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.07085673 |
| 116 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06713991 |
| 117 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.06509651 |
| 118 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.06244457 |
| 119 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.06146921 |
| 120 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.05687397 |
| 121 | GF1_26923725_Chip-Seq_HPCs_Mouse | 1.05299908 |
| 122 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.05040670 |
| 123 | JUN_21703547_ChIP-Seq_K562_Human | 1.04985402 |
| 124 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.03944150 |
| 125 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.03557969 |
| 126 | LMO2_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.02389797 |
| 127 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.02386713 |
| 128 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.00637032 |
| 129 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.00281255 |
| 130 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.00064969 |
| 131 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.99889355 |
| 132 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.99741484 |
| 133 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.99401824 |
| 134 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.98337225 |
| 135 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.95792470 |
| 136 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.95304521 |
| 137 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.95036912 |
| 138 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.94604233 |
| 139 | * SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.94137880 |
| 140 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.93569598 |
| 141 | SPI1_23127762_ChIP-Seq_K562_Human | 0.93474319 |
| 142 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.93422278 |
| 143 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.92105197 |
| 144 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.91505364 |
| 145 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.91449944 |
| 146 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.91449944 |
| 147 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.91431839 |
| 148 | CJUN_26792858_Chip-Seq_BT549_Human | 0.91310914 |
| 149 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.91223882 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005464_abnormal_platelet_physiology | 6.79311211 |
| 2 | MP0008004_abnormal_stomach_pH | 4.55481726 |
| 3 | MP0005551_abnormal_eye_electrophysiolog | 3.65330655 |
| 4 | MP0001968_abnormal_touch/_nociception | 3.44716506 |
| 5 | MP0003880_abnormal_central_pattern | 3.36437048 |
| 6 | MP0002735_abnormal_chemical_nociception | 3.23970323 |
| 7 | MP0001984_abnormal_olfaction | 3.16240357 |
| 8 | MP0004510_myositis | 3.14250195 |
| 9 | MP0004859_abnormal_synaptic_plasticity | 3.10869462 |
| 10 | MP0006276_abnormal_autonomic_nervous | 3.01820445 |
| 11 | MP0002736_abnormal_nociception_after | 2.92279145 |
| 12 | MP0003635_abnormal_synaptic_transmissio | 2.77985497 |
| 13 | MP0002734_abnormal_mechanical_nocicepti | 2.77777229 |
| 14 | MP0000465_gastrointestinal_hemorrhage | 2.72842684 |
| 15 | MP0003724_increased_susceptibility_to | 2.71561822 |
| 16 | MP0004270_analgesia | 2.68149323 |
| 17 | MP0006072_abnormal_retinal_apoptosis | 2.67881466 |
| 18 | MP0001502_abnormal_circadian_rhythm | 2.61878918 |
| 19 | MP0004130_abnormal_muscle_cell | 2.54096646 |
| 20 | MP0009046_muscle_twitch | 2.52127465 |
| 21 | MP0004484_altered_response_of | 2.44661979 |
| 22 | MP0002184_abnormal_innervation | 2.43550095 |
| 23 | MP0002972_abnormal_cardiac_muscle | 2.41161970 |
| 24 | MP0001486_abnormal_startle_reflex | 2.37915815 |
| 25 | MP0002063_abnormal_learning/memory/cond | 2.36403190 |
| 26 | MP0005620_abnormal_muscle_contractility | 2.34908097 |
| 27 | MP0002090_abnormal_vision | 2.32980250 |
| 28 | MP0002272_abnormal_nervous_system | 2.30987656 |
| 29 | MP0001188_hyperpigmentation | 2.28857138 |
| 30 | MP0002064_seizures | 2.24795230 |
| 31 | MP0002067_abnormal_sensory_capabilities | 2.23726018 |
| 32 | MP0009745_abnormal_behavioral_response | 2.20879647 |
| 33 | MP0000230_abnormal_systemic_arterial | 2.20644828 |
| 34 | MP0002572_abnormal_emotion/affect_behav | 2.07732671 |
| 35 | MP0005423_abnormal_somatic_nervous | 2.07655161 |
| 36 | MP0005253_abnormal_eye_physiology | 1.96558646 |
| 37 | MP0005670_abnormal_white_adipose | 1.95061804 |
| 38 | MP0002638_abnormal_pupillary_reflex | 1.92105303 |
| 39 | MP0002733_abnormal_thermal_nociception | 1.89657567 |
| 40 | MP0001970_abnormal_pain_threshold | 1.89644687 |
| 41 | MP0000778_abnormal_nervous_system | 1.85339464 |
| 42 | MP0006138_congestive_heart_failure | 1.84716843 |
| 43 | MP0001879_abnormal_lymphatic_vessel | 1.83909255 |
| 44 | MP0004233_abnormal_muscle_weight | 1.81913389 |
| 45 | MP0004858_abnormal_nervous_system | 1.79139208 |
| 46 | MP0003646_muscle_fatigue | 1.78918936 |
| 47 | MP0005167_abnormal_blood-brain_barrier | 1.78274273 |
| 48 | MP0000343_altered_response_to | 1.74131146 |
| 49 | MP0000749_muscle_degeneration | 1.72390960 |
| 50 | MP0001544_abnormal_cardiovascular_syste | 1.71037640 |
| 51 | MP0005385_cardiovascular_system_phenoty | 1.71037640 |
| 52 | MP0005083_abnormal_biliary_tract | 1.70716835 |
| 53 | MP0006292_abnormal_olfactory_placode | 1.68609513 |
| 54 | MP0003828_pulmonary_edema | 1.65047170 |
| 55 | MP0002752_abnormal_somatic_nervous | 1.61105681 |
| 56 | MP0002557_abnormal_social/conspecific_i | 1.61103683 |
| 57 | MP0002882_abnormal_neuron_morphology | 1.59906948 |
| 58 | MP0005410_abnormal_fertilization | 1.56791970 |
| 59 | MP0004782_abnormal_surfactant_physiolog | 1.55720559 |
| 60 | MP0005499_abnormal_olfactory_system | 1.54531696 |
| 61 | MP0005394_taste/olfaction_phenotype | 1.54531696 |
| 62 | MP0005195_abnormal_posterior_eye | 1.53708196 |
| 63 | MP0010386_abnormal_urinary_bladder | 1.53447446 |
| 64 | MP0001529_abnormal_vocalization | 1.51336463 |
| 65 | MP0000955_abnormal_spinal_cord | 1.50604508 |
| 66 | MP0003718_maternal_effect | 1.49901270 |
| 67 | MP0002106_abnormal_muscle_physiology | 1.47247932 |
| 68 | MP0003136_yellow_coat_color | 1.45896168 |
| 69 | MP0001986_abnormal_taste_sensitivity | 1.45395117 |
| 70 | MP0002751_abnormal_autonomic_nervous | 1.42056786 |
| 71 | MP0008789_abnormal_olfactory_epithelium | 1.42014598 |
| 72 | MP0003879_abnormal_hair_cell | 1.41730017 |
| 73 | MP0000631_abnormal_neuroendocrine_gland | 1.40234976 |
| 74 | MP0002229_neurodegeneration | 1.39934544 |
| 75 | MP0004811_abnormal_neuron_physiology | 1.39548953 |
| 76 | MP0002837_dystrophic_cardiac_calcinosis | 1.35597495 |
| 77 | MP0001501_abnormal_sleep_pattern | 1.35061976 |
| 78 | MP0004142_abnormal_muscle_tone | 1.35049496 |
| 79 | MP0001440_abnormal_grooming_behavior | 1.29882866 |
| 80 | MP0004924_abnormal_behavior | 1.27849902 |
| 81 | MP0005386_behavior/neurological_phenoty | 1.27849902 |
| 82 | MP0003183_abnormal_peptide_metabolism | 1.26461810 |
| 83 | MP0000751_myopathy | 1.26311990 |
| 84 | MP0008569_lethality_at_weaning | 1.25918682 |
| 85 | MP0004087_abnormal_muscle_fiber | 1.24008245 |
| 86 | MP0003566_abnormal_cell_adhesion | 1.23530418 |
| 87 | MP0009780_abnormal_chondrocyte_physiolo | 1.22948699 |
| 88 | MP0005085_abnormal_gallbladder_physiolo | 1.22646813 |
| 89 | MP0003122_maternal_imprinting | 1.19479658 |
| 90 | MP0005409_darkened_coat_color | 1.19470575 |
| 91 | MP0004215_abnormal_myocardial_fiber | 1.19102371 |
| 92 | MP0004145_abnormal_muscle_electrophysio | 1.18328481 |
| 93 | MP0003303_peritoneal_inflammation | 1.18255505 |
| 94 | MP0008260_abnormal_autophagy | 1.18137492 |
| 95 | MP0005646_abnormal_pituitary_gland | 1.17525906 |
| 96 | MP0002822_catalepsy | 1.17521677 |
| 97 | MP0004742_abnormal_vestibular_system | 1.16140554 |
| 98 | MP0005248_abnormal_Harderian_gland | 1.15753514 |
| 99 | MP0003638_abnormal_response/metabolism_ | 1.15463139 |
| 100 | MP0001346_abnormal_lacrimal_gland | 1.14777599 |
| 101 | MP0002066_abnormal_motor_capabilities/c | 1.13743628 |
| 102 | MP0005645_abnormal_hypothalamus_physiol | 1.10862453 |
| 103 | MP0003787_abnormal_imprinting | 1.10255193 |
| 104 | MP0005369_muscle_phenotype | 1.09182132 |
| 105 | MP0005666_abnormal_adipose_tissue | 1.05678346 |
| 106 | MP0001963_abnormal_hearing_physiology | 1.04479382 |
| 107 | MP0009697_abnormal_copulation | 1.02538659 |
| 108 | MP0008775_abnormal_heart_ventricle | 1.01977200 |
| 109 | MP0010368_abnormal_lymphatic_system | 1.00741022 |
| 110 | MP0003634_abnormal_glial_cell | 1.00210587 |
| 111 | MP0000249_abnormal_blood_vessel | 0.99159043 |
| 112 | MP0010329_abnormal_lipoprotein_level | 0.98756829 |
| 113 | MP0005187_abnormal_penis_morphology | 0.97642747 |
| 114 | MP0002152_abnormal_brain_morphology | 0.97280023 |
| 115 | MP0002102_abnormal_ear_morphology | 0.94045905 |
| 116 | MP0005165_increased_susceptibility_to | 0.93514039 |
| 117 | MP0008874_decreased_physiological_sensi | 0.93498854 |
| 118 | MP0003011_delayed_dark_adaptation | 0.91372502 |
| 119 | MP0003137_abnormal_impulse_conducting | 0.91024113 |
| 120 | MP0005084_abnormal_gallbladder_morpholo | 0.90726946 |
| 121 | MP0003950_abnormal_plasma_membrane | 0.89923856 |
| 122 | MP0005330_cardiomyopathy | 0.88624763 |
| 123 | MP0002127_abnormal_cardiovascular_syste | 0.88597337 |
| 124 | MP0004085_abnormal_heartbeat | 0.88224239 |
| 125 | MP0000026_abnormal_inner_ear | 0.86520212 |
| 126 | MP0002069_abnormal_eating/drinking_beha | 0.85354985 |
| 127 | MP0005595_abnormal_vascular_smooth | 0.83695888 |
| 128 | MP0002132_abnormal_respiratory_system | 0.81778911 |
| 129 | MP0001765_abnormal_ion_homeostasis | 0.80524316 |
| 130 | MP0000534_abnormal_ureter_morphology | 0.80296469 |
| 131 | MP0003656_abnormal_erythrocyte_physiolo | 0.80262500 |
| 132 | MP0002909_abnormal_adrenal_gland | 0.80176725 |
| 133 | MP0004036_abnormal_muscle_relaxation | 0.79969720 |
| 134 | MP0010030_abnormal_orbit_morphology | 0.78023221 |
| 135 | MP0001324_abnormal_eye_pigmentation | 0.76342474 |
| 136 | MP0003329_amyloid_beta_deposits | 0.76055335 |
| 137 | MP0002128_abnormal_blood_circulation | 0.75706982 |
| 138 | MP0005535_abnormal_body_temperature | 0.75089360 |
| 139 | MP0010630_abnormal_cardiac_muscle | 0.75086946 |
| 140 | MP0000372_irregular_coat_pigmentation | 0.74963664 |
| 141 | MP0000759_abnormal_skeletal_muscle | 0.73310913 |
| 142 | MP0001905_abnormal_dopamine_level | 0.73090551 |
| 143 | MP0000747_muscle_weakness | 0.72335801 |
| 144 | MP0002971_abnormal_brown_adipose | 0.71394567 |
| 145 | MP0003633_abnormal_nervous_system | 0.71371991 |
| 146 | MP0002653_abnormal_ependyma_morphology | 0.71231717 |
| 147 | MP0001851_eye_inflammation | 0.71030766 |
| 148 | MP0005171_absent_coat_pigmentation | 0.70332213 |
| 149 | MP0000015_abnormal_ear_pigmentation | 0.70239287 |
| 150 | MP0004084_abnormal_cardiac_muscle | 0.69098368 |
| 151 | MP0005365_abnormal_bile_salt | 0.68776531 |
| 152 | MP0004885_abnormal_endolymph | 0.68602617 |
| 153 | MP0005391_vision/eye_phenotype | 0.65748372 |
| 154 | MP0001756_abnormal_urination | 0.65647958 |
| 155 | MP0002332_abnormal_exercise_endurance | 0.65598549 |
| 156 | MP0000750_abnormal_muscle_regeneration | 0.64628552 |
| 157 | MP0003091_abnormal_cell_migration | 0.64074055 |
| 158 | MP0002118_abnormal_lipid_homeostasis | 0.63719859 |
| 159 | MP0006036_abnormal_mitochondrial_physio | 0.63263211 |
| 160 | MP0008872_abnormal_physiological_respon | 0.63249547 |
| 161 | MP0009642_abnormal_blood_homeostasis | 0.62127483 |
| 162 | MP0001270_distended_abdomen | 0.61674958 |
| 163 | MP0001664_abnormal_digestion | 0.61431247 |
| 164 | MP0001663_abnormal_digestive_system | 0.61393892 |
| 165 | MP0001299_abnormal_eye_distance/ | 0.61200501 |
| 166 | MP0003631_nervous_system_phenotype | 0.61144036 |
| 167 | MP0009763_increased_sensitivity_to | 0.60012229 |
| 168 | MP0000569_abnormal_digit_pigmentation | 0.59324343 |
| 169 | MP0003861_abnormal_nervous_system | 0.58962018 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Congenital stationary night blindness (HP:0007642) | 8.99186252 |
| 2 | Prolonged bleeding time (HP:0003010) | 8.59427610 |
| 3 | Increased mean platelet volume (HP:0011877) | 8.19865777 |
| 4 | Menorrhagia (HP:0000132) | 8.16737577 |
| 5 | Abnormal platelet volume (HP:0011876) | 7.57101995 |
| 6 | Petechiae (HP:0000967) | 6.87880730 |
| 7 | Purpura (HP:0000979) | 6.42095560 |
| 8 | Febrile seizures (HP:0002373) | 5.94750398 |
| 9 | Central scotoma (HP:0000603) | 5.64250084 |
| 10 | Epistaxis (HP:0000421) | 5.59403318 |
| 11 | Epileptic encephalopathy (HP:0200134) | 5.40628675 |
| 12 | Severe visual impairment (HP:0001141) | 5.28214247 |
| 13 | Abnormality of macular pigmentation (HP:0008002) | 5.16853918 |
| 14 | Gingival bleeding (HP:0000225) | 5.03748590 |
| 15 | Septo-optic dysplasia (HP:0100842) | 4.43806168 |
| 16 | Bundle branch block (HP:0011710) | 4.37879012 |
| 17 | Hyperlipoproteinemia (HP:0010980) | 4.35306254 |
| 18 | Abnormal platelet function (HP:0011869) | 4.16905877 |
| 19 | Impaired platelet aggregation (HP:0003540) | 4.16905877 |
| 20 | Focal motor seizures (HP:0011153) | 4.13014471 |
| 21 | Myokymia (HP:0002411) | 4.08361613 |
| 22 | Ulnar claw (HP:0001178) | 4.05396696 |
| 23 | Absence seizures (HP:0002121) | 4.04875120 |
| 24 | Muscle fiber inclusion bodies (HP:0100299) | 3.99361542 |
| 25 | Muscle fiber splitting (HP:0003555) | 3.88730383 |
| 26 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.88501143 |
| 27 | Progressive cerebellar ataxia (HP:0002073) | 3.85273441 |
| 28 | Nemaline bodies (HP:0003798) | 3.83841309 |
| 29 | Abnormal rod and cone electroretinograms (HP:0008323) | 3.81919306 |
| 30 | Spontaneous hematomas (HP:0007420) | 3.75165554 |
| 31 | Acanthocytosis (HP:0001927) | 3.57074569 |
| 32 | Scotoma (HP:0000575) | 3.53654262 |
| 33 | Dialeptic seizures (HP:0011146) | 3.52340157 |
| 34 | Action tremor (HP:0002345) | 3.50372015 |
| 35 | Atonic seizures (HP:0010819) | 3.45018695 |
| 36 | Poikilocytosis (HP:0004447) | 3.43026253 |
| 37 | Focal seizures (HP:0007359) | 3.39500258 |
| 38 | Hyporeflexia of lower limbs (HP:0002600) | 3.34471347 |
| 39 | Sudden death (HP:0001699) | 3.33735671 |
| 40 | Decreased central vision (HP:0007663) | 3.23025447 |
| 41 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 3.22145361 |
| 42 | Hypoplasia of the fovea (HP:0007750) | 3.22145361 |
| 43 | Gait imbalance (HP:0002141) | 3.15296997 |
| 44 | Conjunctival telangiectasia (HP:0000524) | 3.11562074 |
| 45 | Ventricular fibrillation (HP:0001663) | 3.07014797 |
| 46 | Papillary thyroid carcinoma (HP:0002895) | 3.00745411 |
| 47 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.00079654 |
| 48 | Subaortic stenosis (HP:0001682) | 3.00079654 |
| 49 | Keratoconus (HP:0000563) | 2.99838007 |
| 50 | Increased corneal curvature (HP:0100692) | 2.99838007 |
| 51 | Dyschromatopsia (HP:0007641) | 2.95314772 |
| 52 | Exercise-induced myalgia (HP:0003738) | 2.95311280 |
| 53 | Visual hallucinations (HP:0002367) | 2.92892268 |
| 54 | Generalized tonic-clonic seizures (HP:0002069) | 2.82528656 |
| 55 | Insidious onset (HP:0003587) | 2.79252092 |
| 56 | Termporal pattern (HP:0011008) | 2.79252092 |
| 57 | Polyphagia (HP:0002591) | 2.79179127 |
| 58 | Congenital primary aphakia (HP:0007707) | 2.78107186 |
| 59 | Medial flaring of the eyebrow (HP:0010747) | 2.75221775 |
| 60 | Abnormal pupillary function (HP:0007686) | 2.74313918 |
| 61 | Type 1 muscle fiber predominance (HP:0003803) | 2.73255146 |
| 62 | Mutism (HP:0002300) | 2.72263191 |
| 63 | Exercise-induced muscle cramps (HP:0003710) | 2.70729030 |
| 64 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.70123404 |
| 65 | Abnormality of the fovea (HP:0000493) | 2.68189891 |
| 66 | Nephrogenic diabetes insipidus (HP:0009806) | 2.67470392 |
| 67 | Abnormality of the calf musculature (HP:0001430) | 2.65401339 |
| 68 | Ventricular tachycardia (HP:0004756) | 2.65200780 |
| 69 | Optic nerve hypoplasia (HP:0000609) | 2.64132364 |
| 70 | Abnormality of lateral ventricle (HP:0030047) | 2.62049444 |
| 71 | Calf muscle hypertrophy (HP:0008981) | 2.57629925 |
| 72 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.56951896 |
| 73 | Atrial fibrillation (HP:0005110) | 2.56777205 |
| 74 | Increased density of long bones (HP:0006392) | 2.55461572 |
| 75 | Abnormal auditory evoked potentials (HP:0006958) | 2.53974181 |
| 76 | Bruising susceptibility (HP:0000978) | 2.50299343 |
| 77 | Distal lower limb amyotrophy (HP:0008944) | 2.47586305 |
| 78 | Limb dystonia (HP:0002451) | 2.47382410 |
| 79 | Absent septum pellucidum (HP:0001331) | 2.45574665 |
| 80 | Paralysis (HP:0003470) | 2.45049250 |
| 81 | Heart block (HP:0012722) | 2.44739896 |
| 82 | Syncope (HP:0001279) | 2.44394222 |
| 83 | Drooling (HP:0002307) | 2.43460448 |
| 84 | Excessive salivation (HP:0003781) | 2.43460448 |
| 85 | Abnormal hair whorl (HP:0010721) | 2.41532698 |
| 86 | Primary atrial arrhythmia (HP:0001692) | 2.41274363 |
| 87 | Hemiparesis (HP:0001269) | 2.41051406 |
| 88 | Frequent falls (HP:0002359) | 2.40610164 |
| 89 | Rimmed vacuoles (HP:0003805) | 2.40505652 |
| 90 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.34966644 |
| 91 | Abnormality of the common coagulation pathway (HP:0010990) | 2.34289695 |
| 92 | Cholecystitis (HP:0001082) | 2.33226575 |
| 93 | Abnormal gallbladder physiology (HP:0012438) | 2.33226575 |
| 94 | Genital tract atresia (HP:0001827) | 2.33050290 |
| 95 | Steppage gait (HP:0003376) | 2.31329352 |
| 96 | Distal lower limb muscle weakness (HP:0009053) | 2.29208501 |
| 97 | Supranuclear gaze palsy (HP:0000605) | 2.29160993 |
| 98 | Abnormal atrioventricular conduction (HP:0005150) | 2.28772946 |
| 99 | Fetal akinesia sequence (HP:0001989) | 2.27281443 |
| 100 | EEG with generalized epileptiform discharges (HP:0011198) | 2.27179919 |
| 101 | Supraventricular tachycardia (HP:0004755) | 2.26888631 |
| 102 | Epileptiform EEG discharges (HP:0011182) | 2.26843649 |
| 103 | Albinism (HP:0001022) | 2.26273346 |
| 104 | Vaginal atresia (HP:0000148) | 2.25130545 |
| 105 | Ankle clonus (HP:0011448) | 2.24648411 |
| 106 | Hypoplasia of the brainstem (HP:0002365) | 2.24355859 |
| 107 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 2.24355859 |
| 108 | Aplasia/Hypoplasia affecting the fundus (HP:0008057) | 2.23926791 |
| 109 | Supraventricular arrhythmia (HP:0005115) | 2.22874737 |
| 110 | Retinal dysplasia (HP:0007973) | 2.21756326 |
| 111 | Lipoatrophy (HP:0100578) | 2.20234708 |
| 112 | Growth hormone deficiency (HP:0000824) | 2.17438883 |
| 113 | Generalized aminoaciduria (HP:0002909) | 2.17161917 |
| 114 | Abnormal eating behavior (HP:0100738) | 2.17050135 |
| 115 | EMG: myopathic abnormalities (HP:0003458) | 2.16081428 |
| 116 | Lower limb amyotrophy (HP:0007210) | 2.13784625 |
| 117 | Pheochromocytoma (HP:0002666) | 2.12338610 |
| 118 | Generalized hypopigmentation (HP:0007513) | 2.11909151 |
| 119 | Hypophosphatemic rickets (HP:0004912) | 2.11485489 |
| 120 | Failure to thrive in infancy (HP:0001531) | 2.11470569 |
| 121 | Poor coordination (HP:0002370) | 2.09067753 |
| 122 | Dysdiadochokinesis (HP:0002075) | 2.07311715 |
| 123 | Specific learning disability (HP:0001328) | 2.07153990 |
| 124 | Ventricular arrhythmia (HP:0004308) | 2.06749674 |
| 125 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.06694113 |
| 126 | Abnormality of the septum pellucidum (HP:0007375) | 2.06349679 |
| 127 | Hypothermia (HP:0002045) | 2.05570723 |
| 128 | Nausea (HP:0002018) | 2.05542311 |
| 129 | Aplasia/Hypoplasia of the macula (HP:0008059) | 2.05162214 |
| 130 | Thyroid-stimulating hormone excess (HP:0002925) | 2.05116407 |
| 131 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.05097173 |
| 132 | Prolonged QT interval (HP:0001657) | 2.04911294 |
| 133 | Myoglobinuria (HP:0002913) | 2.04545388 |
| 134 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 2.03777521 |
| 135 | Hypoventilation (HP:0002791) | 2.01560059 |
| 136 | Difficulty running (HP:0009046) | 2.00225159 |
| 137 | Abnormality of the lower motor neuron (HP:0002366) | 1.98763438 |
| 138 | Areflexia of lower limbs (HP:0002522) | 1.97812303 |
| 139 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.97120244 |
| 140 | Dilated cardiomyopathy (HP:0001644) | 1.96932937 |
| 141 | Hyperventilation (HP:0002883) | 1.96918394 |
| 142 | Narrow nasal bridge (HP:0000446) | 1.96810365 |
| 143 | Depression (HP:0000716) | 1.96113099 |
| 144 | Distal arthrogryposis (HP:0005684) | 1.95928930 |
| 145 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.93806701 |
| 146 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.92984126 |
| 147 | Upper limb muscle weakness (HP:0003484) | 1.92983815 |
| 148 | Abnormality of the vocal cords (HP:0008777) | 1.92314369 |
| 149 | Tinnitus (HP:0000360) | 1.92120026 |
| 150 | Severe Myopia (HP:0011003) | 1.90351469 |
| 151 | Gaze-evoked nystagmus (HP:0000640) | 1.88503137 |
| 152 | Truncal ataxia (HP:0002078) | 1.88025595 |
| 153 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 1.87692946 |
| 154 | EMG: neuropathic changes (HP:0003445) | 1.85258382 |
| 155 | Neck muscle weakness (HP:0000467) | 1.83936939 |
| 156 | Biliary tract neoplasm (HP:0100574) | 1.83886614 |
| 157 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.82707381 |
| 158 | Hammertoe (HP:0001765) | 1.82253851 |
| 159 | Absent speech (HP:0001344) | 1.81925943 |
| 160 | Amblyopia (HP:0000646) | 1.81627980 |
| 161 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.81404461 |
| 162 | Increased variability in muscle fiber diameter (HP:0003557) | 1.81024845 |
| 163 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.81024675 |
| 164 | Neuroendocrine neoplasm (HP:0100634) | 1.80980381 |
| 165 | Hypsarrhythmia (HP:0002521) | 1.80719424 |
| 166 | Asymmetric septal hypertrophy (HP:0001670) | 1.80694335 |
| 167 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 1.80391707 |
| 168 | Genetic anticipation (HP:0003743) | 1.79049697 |
| 169 | Thyroid carcinoma (HP:0002890) | 1.76737901 |
| 170 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.76668226 |
| 171 | Scanning speech (HP:0002168) | 1.76631302 |
| 172 | Congenital sensorineural hearing impairment (HP:0008527) | 1.75840842 |
| 173 | Difficulty walking (HP:0002355) | 1.72983263 |
| 174 | Esotropia (HP:0000565) | 1.72490211 |
| 175 | Polycythemia (HP:0001901) | 1.71811624 |
| 176 | Broad-based gait (HP:0002136) | 1.70769968 |
| 177 | Spastic gait (HP:0002064) | 1.69381518 |
| 178 | Astigmatism (HP:0000483) | 1.69127850 |
| 179 | Joint hemorrhage (HP:0005261) | 1.67918880 |
| 180 | Muscle fibrillation (HP:0010546) | 1.67894357 |
| 181 | Impaired proprioception (HP:0010831) | 1.67833796 |
| 182 | Xanthomatosis (HP:0000991) | 1.67310357 |
| 183 | Abnormality of salivation (HP:0100755) | 1.67072350 |
| 184 | Left ventricular hypertrophy (HP:0001712) | 1.66656453 |
| 185 | Gowers sign (HP:0003391) | 1.64088320 |
| 186 | Male infertility (HP:0003251) | 1.62229402 |
| 187 | Mitral stenosis (HP:0001718) | 1.61283755 |
| 188 | Tongue fasciculations (HP:0001308) | 1.61142648 |
| 189 | Abnormal EKG (HP:0003115) | 1.60776752 |
| 190 | Generalized muscle weakness (HP:0003324) | 1.58866675 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 4.61281488 |
| 2 | MARK1 | 4.20482457 |
| 3 | OBSCN | 4.19588456 |
| 4 | MAP3K4 | 3.51710501 |
| 5 | MYLK | 3.44073768 |
| 6 | MINK1 | 3.05414601 |
| 7 | MAP2K7 | 2.96640560 |
| 8 | BMX | 2.94582565 |
| 9 | MST4 | 2.89052392 |
| 10 | NTRK3 | 2.80722981 |
| 11 | RIPK4 | 2.70167746 |
| 12 | PAK6 | 2.70143057 |
| 13 | PRPF4B | 2.38056727 |
| 14 | TEC | 2.30588946 |
| 15 | PTK2B | 2.27599510 |
| 16 | PHKG1 | 2.27436101 |
| 17 | PHKG2 | 2.27436101 |
| 18 | PIK3CG | 2.24909634 |
| 19 | MAPK13 | 2.14657035 |
| 20 | EIF2AK1 | 2.12244954 |
| 21 | MAP3K9 | 1.97593456 |
| 22 | NME1 | 1.85306726 |
| 23 | TAOK3 | 1.84943017 |
| 24 | AKT3 | 1.74797290 |
| 25 | SIK3 | 1.72234740 |
| 26 | NTRK2 | 1.72058694 |
| 27 | NEK1 | 1.63111985 |
| 28 | TTN | 1.62763204 |
| 29 | ARAF | 1.62138146 |
| 30 | DYRK1A | 1.51625547 |
| 31 | EPHA4 | 1.49752100 |
| 32 | MAP2K4 | 1.48201153 |
| 33 | MAPKAPK3 | 1.47273139 |
| 34 | SGK223 | 1.42515029 |
| 35 | SGK494 | 1.42515029 |
| 36 | BTK | 1.39832393 |
| 37 | CSF1R | 1.39191262 |
| 38 | CDK8 | 1.36902983 |
| 39 | TNIK | 1.36395980 |
| 40 | SGK2 | 1.34361257 |
| 41 | PLK2 | 1.33296839 |
| 42 | DAPK2 | 1.32795069 |
| 43 | LMTK2 | 1.27897937 |
| 44 | FGR | 1.26063625 |
| 45 | ACVR1B | 1.24954825 |
| 46 | LATS2 | 1.24784140 |
| 47 | STK24 | 1.24480501 |
| 48 | GRK5 | 1.23081928 |
| 49 | TNK2 | 1.19752606 |
| 50 | DMPK | 1.19323776 |
| 51 | MAP3K12 | 1.19045395 |
| 52 | SYK | 1.19045113 |
| 53 | MAPK12 | 1.16890096 |
| 54 | CDK5 | 1.16470109 |
| 55 | ILK | 1.16368222 |
| 56 | PRKCG | 1.13715819 |
| 57 | PKN2 | 1.11430366 |
| 58 | PINK1 | 1.08770734 |
| 59 | ERBB3 | 1.08379596 |
| 60 | EPHA3 | 1.05865659 |
| 61 | EPHB2 | 1.05521323 |
| 62 | STK38 | 1.04781173 |
| 63 | DYRK2 | 1.04113175 |
| 64 | ZAP70 | 1.03502399 |
| 65 | TAOK2 | 1.02151383 |
| 66 | KSR1 | 1.01909077 |
| 67 | PRKCE | 0.97682723 |
| 68 | CDK14 | 0.96474095 |
| 69 | INSRR | 0.95614480 |
| 70 | CAMK2A | 0.95477282 |
| 71 | MAP3K6 | 0.94829722 |
| 72 | STK3 | 0.93908780 |
| 73 | FER | 0.91933574 |
| 74 | CDK18 | 0.91073118 |
| 75 | MAP3K5 | 0.91001972 |
| 76 | UHMK1 | 0.89399906 |
| 77 | PRKD1 | 0.87940328 |
| 78 | NTRK1 | 0.85478909 |
| 79 | CAMK2D | 0.85291047 |
| 80 | YES1 | 0.84671367 |
| 81 | WNK3 | 0.83856354 |
| 82 | GRK6 | 0.83248543 |
| 83 | CDK15 | 0.82388433 |
| 84 | BCR | 0.79478779 |
| 85 | PKN1 | 0.77643958 |
| 86 | SIK2 | 0.76860673 |
| 87 | TRIM28 | 0.76289016 |
| 88 | FRK | 0.75946876 |
| 89 | HCK | 0.75695841 |
| 90 | PNCK | 0.72552491 |
| 91 | CSNK1G2 | 0.72382073 |
| 92 | IRAK2 | 0.71647464 |
| 93 | SGK3 | 0.71627944 |
| 94 | CDK11A | 0.71529010 |
| 95 | PAK3 | 0.69698733 |
| 96 | PDK1 | 0.68760374 |
| 97 | IRAK1 | 0.68496538 |
| 98 | PIM2 | 0.67965056 |
| 99 | STK39 | 0.67007052 |
| 100 | CAMKK2 | 0.66545914 |
| 101 | PRKACG | 0.66537226 |
| 102 | BMPR2 | 0.63537114 |
| 103 | CDK3 | 0.63209906 |
| 104 | TIE1 | 0.63188604 |
| 105 | FES | 0.61949944 |
| 106 | RPS6KA2 | 0.61705460 |
| 107 | MAP2K3 | 0.59752891 |
| 108 | CAMK2B | 0.59008422 |
| 109 | ADRBK2 | 0.58781005 |
| 110 | PAK1 | 0.58351847 |
| 111 | ADRBK1 | 0.58334835 |
| 112 | BRAF | 0.56994652 |
| 113 | TAOK1 | 0.56708733 |
| 114 | PRKG1 | 0.56634843 |
| 115 | ERBB2 | 0.56468862 |
| 116 | EPHB1 | 0.55552896 |
| 117 | PRKACA | 0.55480567 |
| 118 | PRKAA1 | 0.54494637 |
| 119 | RAF1 | 0.53336296 |
| 120 | PRKCZ | 0.53101632 |
| 121 | MET | 0.52599256 |
| 122 | BMPR1B | 0.52562274 |
| 123 | MAP4K2 | 0.52410583 |
| 124 | CAMK1 | 0.51598260 |
| 125 | MARK2 | 0.51398374 |
| 126 | KSR2 | 0.51378389 |
| 127 | DAPK1 | 0.51292776 |
| 128 | GRK7 | 0.51275445 |
| 129 | LIMK1 | 0.50814459 |
| 130 | MAP2K1 | 0.50670412 |
| 131 | CAMK2G | 0.50252006 |
| 132 | CCNB1 | 0.50246599 |
| 133 | DDR2 | 0.50064567 |
| 134 | PDPK1 | 0.49935387 |
| 135 | PIK3CA | 0.49415615 |
| 136 | PRKCB | 0.49046563 |
| 137 | NEK9 | 0.47992048 |
| 138 | ROCK2 | 0.46547910 |
| 139 | STK38L | 0.46505469 |
| 140 | MARK3 | 0.46487669 |
| 141 | MAPK10 | 0.46370568 |
| 142 | DYRK1B | 0.45015070 |
| 143 | SGK1 | 0.44807489 |
| 144 | OXSR1 | 0.43450177 |
| 145 | MAP3K7 | 0.43091607 |
| 146 | CAMKK1 | 0.42826845 |
| 147 | RPS6KA3 | 0.42776096 |
| 148 | WNK1 | 0.42275121 |
| 149 | PRKCA | 0.42253796 |
| 150 | ROCK1 | 0.42120812 |
| 151 | LYN | 0.41941408 |
| 152 | MAPK9 | 0.41488280 |
| 153 | NEK6 | 0.40525187 |
| 154 | CSNK1G3 | 0.39183326 |
| 155 | RET | 0.38435365 |
| 156 | PLK3 | 0.37983314 |
| 157 | PRKACB | 0.36786723 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.84844262 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 4.03721222 |
| 3 | Platelet activation_Homo sapiens_hsa04611 | 3.87029476 |
| 4 | GABAergic synapse_Homo sapiens_hsa04727 | 3.38572982 |
| 5 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 3.26603023 |
| 6 | Morphine addiction_Homo sapiens_hsa05032 | 3.07306155 |
| 7 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 2.63088414 |
| 8 | Olfactory transduction_Homo sapiens_hsa04740 | 2.50766348 |
| 9 | Circadian entrainment_Homo sapiens_hsa04713 | 2.47568680 |
| 10 | Insulin secretion_Homo sapiens_hsa04911 | 2.07047800 |
| 11 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.06818475 |
| 12 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.03864995 |
| 13 | Serotonergic synapse_Homo sapiens_hsa04726 | 2.03315839 |
| 14 | Phototransduction_Homo sapiens_hsa04744 | 2.00878559 |
| 15 | Taste transduction_Homo sapiens_hsa04742 | 2.00853703 |
| 16 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.99368425 |
| 17 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.90733104 |
| 18 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.90581500 |
| 19 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.84933232 |
| 20 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.84530456 |
| 21 | Salivary secretion_Homo sapiens_hsa04970 | 1.81376371 |
| 22 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.78216903 |
| 23 | Renin secretion_Homo sapiens_hsa04924 | 1.75077888 |
| 24 | Circadian rhythm_Homo sapiens_hsa04710 | 1.71418135 |
| 25 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.69803688 |
| 26 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.62757205 |
| 27 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.45564803 |
| 28 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.42200111 |
| 29 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.40403655 |
| 30 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.39866490 |
| 31 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.39718936 |
| 32 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.36523193 |
| 33 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.33425589 |
| 34 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.30498592 |
| 35 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.28709921 |
| 36 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.23961351 |
| 37 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.23550444 |
| 38 | Long-term depression_Homo sapiens_hsa04730 | 1.22019988 |
| 39 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.21725712 |
| 40 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.20588328 |
| 41 | Axon guidance_Homo sapiens_hsa04360 | 1.20077301 |
| 42 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.19858572 |
| 43 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.18096529 |
| 44 | Gap junction_Homo sapiens_hsa04540 | 1.17519985 |
| 45 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.15586113 |
| 46 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.14719427 |
| 47 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.13376789 |
| 48 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.11522832 |
| 49 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.10188544 |
| 50 | Focal adhesion_Homo sapiens_hsa04510 | 1.08899656 |
| 51 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.08577692 |
| 52 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.08327516 |
| 53 | Long-term potentiation_Homo sapiens_hsa04720 | 1.08272452 |
| 54 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.07570021 |
| 55 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.06643978 |
| 56 | Cocaine addiction_Homo sapiens_hsa05030 | 1.04363686 |
| 57 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.03138734 |
| 58 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.02267514 |
| 59 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.01180683 |
| 60 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.99435217 |
| 61 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.96896018 |
| 62 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.94466367 |
| 63 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.93775017 |
| 64 | Adherens junction_Homo sapiens_hsa04520 | 0.89487253 |
| 65 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.88907103 |
| 66 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.87340540 |
| 67 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.87101416 |
| 68 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.86461318 |
| 69 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.84542067 |
| 70 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.84184988 |
| 71 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.83407731 |
| 72 | Bile secretion_Homo sapiens_hsa04976 | 0.83239119 |
| 73 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.82605332 |
| 74 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.82103670 |
| 75 | Mineral absorption_Homo sapiens_hsa04978 | 0.81732265 |
| 76 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.80348185 |
| 77 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.79939833 |
| 78 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.77939133 |
| 79 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.77798147 |
| 80 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.77234920 |
| 81 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.76350821 |
| 82 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.75522255 |
| 83 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.72798115 |
| 84 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.67697582 |
| 85 | Alzheimers disease_Homo sapiens_hsa05010 | 0.66811482 |
| 86 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.65883520 |
| 87 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.65811782 |
| 88 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.65085536 |
| 89 | Alcoholism_Homo sapiens_hsa05034 | 0.62967176 |
| 90 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.62572000 |
| 91 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.62422766 |
| 92 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.61332119 |
| 93 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.60297412 |
| 94 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.60277730 |
| 95 | Tight junction_Homo sapiens_hsa04530 | 0.59377493 |
| 96 | ABC transporters_Homo sapiens_hsa02010 | 0.58570191 |
| 97 | Parkinsons disease_Homo sapiens_hsa05012 | 0.57744652 |
| 98 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.56298645 |
| 99 | Phagosome_Homo sapiens_hsa04145 | 0.55163101 |
| 100 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.54329707 |
| 101 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.53549488 |
| 102 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.52857485 |
| 103 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.52795857 |
| 104 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.50977674 |
| 105 | Melanoma_Homo sapiens_hsa05218 | 0.50457743 |
| 106 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.49590425 |
| 107 | Amoebiasis_Homo sapiens_hsa05146 | 0.48846635 |
| 108 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.48787280 |
| 109 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.47925836 |
| 110 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.46117346 |
| 111 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.46080284 |
| 112 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.45721664 |
| 113 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.45332379 |
| 114 | Endometrial cancer_Homo sapiens_hsa05213 | 0.45330191 |
| 115 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.43674926 |
| 116 | Galactose metabolism_Homo sapiens_hsa00052 | 0.42231138 |
| 117 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.41401732 |
| 118 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.41099953 |
| 119 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.40860370 |
| 120 | Shigellosis_Homo sapiens_hsa05131 | 0.40719178 |
| 121 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.39305311 |
| 122 | Melanogenesis_Homo sapiens_hsa04916 | 0.39282497 |
| 123 | Colorectal cancer_Homo sapiens_hsa05210 | 0.38702307 |
| 124 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.37334108 |
| 125 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.36941980 |
| 126 | Glioma_Homo sapiens_hsa05214 | 0.34272166 |
| 127 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.33236904 |
| 128 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.32124320 |
| 129 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.31930571 |
| 130 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.31184259 |
| 131 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.31068437 |
| 132 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.30869503 |
| 133 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.29517523 |
| 134 | Huntingtons disease_Homo sapiens_hsa05016 | 0.27832673 |
| 135 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.27455704 |
| 136 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.27088688 |
| 137 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.25335217 |
| 138 | Endocytosis_Homo sapiens_hsa04144 | 0.25231820 |
| 139 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.19413809 |
| 140 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.19017231 |
| 141 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.18241561 |

